Search Results for: OGT

717 interactions involving OGT - O-linked N-acetylglucosamine (GlcNAc) transferase found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
LETM1 leucine zipper and EF-hand containing transmembrane protein 1
  • Mitochondrial calcium ion transport
  • RHOG GTPase cycle
  • Complex III assembly
LMAN1 lectin, mannose binding 1
  • COPII-mediated vesicle transport
  • Cargo concentration in the ER
  • RHOA GTPase cycle
  • RHOC GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOG GTPase cycle
  • RAC3 GTPase cycle
  • Transport to the Golgi and subsequent modification
  • Antihemophilic factor, human recombinant
  • Lonoctocog alfa
  • Moroctocog alfa
  • Combined deficiency of factors V and VIII (F5F8D)
LMNA lamin A/C
  • XBP1(S) activates chaperone genes
  • Signaling by BRAF and RAF1 fusions
  • Mandibuloacral dysplasia
  • Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
  • Emery-Dreifuss muscular dystrophy
  • Dilated cardiomyopathy (DCM)
  • Limb-girdle muscular dystrophy (LGMD)
  • Hutchinson-Gilford progeria syndrome
  • Restrictive dermopathy
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
LNPK lunapark, ER junction formation factor
LPCAT1 lysophosphatidylcholine acyltransferase 1
  • Acyl chain remodelling of PC
  • Acyl chain remodelling of PG
  • Synthesis of PA
  • Synthesis of PC
  • Neutrophil degranulation
LPCAT4 lysophosphatidylcholine acyltransferase 4
  • Acyl chain remodelling of PC
  • Acyl chain remodelling of PS
  • Acyl chain remodelling of PE
  • Acyl chain remodelling of PG
  • Synthesis of PA
LRP4 LDL receptor related protein 4
  • ECM proteoglycans
  • Cenani-Lenz syndactyly syndrome
LRRFIP2 LRR binding FLII interacting protein 2
LSM14A LSM14A mRNA processing body assembly factor
LSM14B LSM family member 14B
LSR lipolysis stimulated lipoprotein receptor
  • LDL clearance
  • VLDL clearance
LTV1 LTV1 ribosome biogenesis factor
  • Major pathway of rRNA processing in the nucleolus and cytosol
LUC7L2 LUC7 like 2, pre-mRNA splicing factor
LUC7L3 LUC7 like 3 pre-mRNA splicing factor
  • mRNA Splicing - Major Pathway
LYAR Ly1 antibody reactive
MAP1A microtubule associated protein 1A
  • Estramustine
MAP7D1 MAP7 domain containing 1
MAPT microtubule associated protein tau
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Lansoprazole
  • Astemizole
  • Paclitaxel
  • Docetaxel
  • Flortaucipir F-18
  • Progressive supranuclear palsy (PSP); Steele-Richardson-Olszewski syndrome
  • Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
  • Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
MARS2 methionyl-tRNA synthetase 2, mitochondrial
  • Mitochondrial tRNA aminoacylation
MAT2A methionine adenosyltransferase 2A
  • Methylation
  • Ademetionine

Page 16 out of 36 pages